Collegium Pharmaceutical, Inc (COLL) bonds
Close on Nov 12, 2026Market cap $812.26MP/E 24.9Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Collegium Pharmaceutical reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2019
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Collegium Pharmaceutical's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Matures | Amount issued | Carrying value |
|---|---|---|---|---|
| 2026 Convertible Notes Convertible | 2.62% | 2026 | $143.75M | $26.35M |
| 2029 Convertible Notes Convertible at $37 a share | 2.88% | 2029 | $241.50M | $241.50M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| 2025 Credit Agreement | $300.00M | $865.50M |
See a number that looks wrong?